Javascript must be enabled to continue!
Risk Factors Analysis of Nontuberculous Mycobacterial Pulmonary Infection in Hospitalized Patients in Yulin, China
View through CrossRef
Background:
Nontuberculous mycobacterial lung disease (NTM-LD) is an increasingly serious chronic lung infection, especially in people with low immune function.
Methods:
This study collected clinical inpatient data from January 2020 to December 2024 at the First People’s Hospital of Yulin, aiming to evaluate the risk factors for nontuberculous mycobacterial (NTM) infection.
Results:
A study involving 199 patients found that 143 (71.86%) were infected with Mycobacterium tuberculosis (MTB), whereas 56 (28.14%) were infected with NTM. The most common NTM species were Mycobacteroides abscessus, accounting for 53.57% (30/56), followed by Mycobacterium intracellulare at 10.71% (6/56). The NTM separation department mainly focuses on respiratory medicine, accounting for 80.36% (45/56) of cases. The median age of the patients is 60 years. The risk factors associated with NTM infection include age (45–65), autoimmune diseases, chronic obstructive pulmonary disease, bronchiectasis, concomitant pulmonary aspergillosis, and immunosuppressant use. Among these, bronchiectasis is an independent risk factor for infection (odds ratio [OR]: 7.357, 95% confidence interval [CI] 3.080–17.574). In addition, expectoration is a significant risk factor for rapidly growing mycobacteria (RGM) infection in NTM-LD (OR: 4.278, 95% CI 1.314–13.928).
Conclusions:
Over one-third of patients suspected of having tuberculosis are actually infected with NTM, and those with bronchiectasis have a higher risk of NTM infection. The most common NTM-LD strain is M. abscessus, which is clinically associated with expectoration as a risk factor for RGM infection.
Ovid Technologies (Wolters Kluwer Health)
Title: Risk Factors Analysis of Nontuberculous Mycobacterial Pulmonary Infection in Hospitalized Patients in Yulin, China
Description:
Background:
Nontuberculous mycobacterial lung disease (NTM-LD) is an increasingly serious chronic lung infection, especially in people with low immune function.
Methods:
This study collected clinical inpatient data from January 2020 to December 2024 at the First People’s Hospital of Yulin, aiming to evaluate the risk factors for nontuberculous mycobacterial (NTM) infection.
Results:
A study involving 199 patients found that 143 (71.
86%) were infected with Mycobacterium tuberculosis (MTB), whereas 56 (28.
14%) were infected with NTM.
The most common NTM species were Mycobacteroides abscessus, accounting for 53.
57% (30/56), followed by Mycobacterium intracellulare at 10.
71% (6/56).
The NTM separation department mainly focuses on respiratory medicine, accounting for 80.
36% (45/56) of cases.
The median age of the patients is 60 years.
The risk factors associated with NTM infection include age (45–65), autoimmune diseases, chronic obstructive pulmonary disease, bronchiectasis, concomitant pulmonary aspergillosis, and immunosuppressant use.
Among these, bronchiectasis is an independent risk factor for infection (odds ratio [OR]: 7.
357, 95% confidence interval [CI] 3.
080–17.
574).
In addition, expectoration is a significant risk factor for rapidly growing mycobacteria (RGM) infection in NTM-LD (OR: 4.
278, 95% CI 1.
314–13.
928).
Conclusions:
Over one-third of patients suspected of having tuberculosis are actually infected with NTM, and those with bronchiectasis have a higher risk of NTM infection.
The most common NTM-LD strain is M.
abscessus, which is clinically associated with expectoration as a risk factor for RGM infection.
Related Results
Mycobacterium Tuberculosis and Nontuberculous Mycobacteria Isolates from Presumptive Pulmonary Tuberculosis Patients Attending A Tertiary Hospital in Addis Ababa, Ethiopia
Mycobacterium Tuberculosis and Nontuberculous Mycobacteria Isolates from Presumptive Pulmonary Tuberculosis Patients Attending A Tertiary Hospital in Addis Ababa, Ethiopia
BACKGROUND፡ Mycobacterial infections are known to cause a public health problem globally. The burden of pulmonary disease from nontuberculous mycobacteria is reportedly on the rise...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
<p dir="ltr"><b>BACKGROUND:</b><br><br>Most forms of pulmonary hypertension carry unsatisfactory prognosis with the notable exception of chronic throm...
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
<p dir="ltr"><b>BACKGROUND:</b><br><br>Most forms of pulmonary hypertension carry unsatisfactory prognosis with the notable exception of chronic throm...
Scrofuloderma and Sweet’s syndrome
Scrofuloderma and Sweet’s syndrome
AbstractBackground In recent years, the rare association of Sweet’s syndrome with nontuberculous mycobacterial lymphadenitis has been reported.Objective To report the clinical, dem...
Video-assisted thoracoscopic surgery for nontuberculous mycobacterial infection
Video-assisted thoracoscopic surgery for nontuberculous mycobacterial infection
Background
The number of patients with nontuberculous mycobacterium infection is increasing in Japan, and therefore surgical treatment is also being applied wit...
Effect of Polybasic Amines on the Immunogenicity of Mycobacterial Ribonucleic Acid
Effect of Polybasic Amines on the Immunogenicity of Mycobacterial Ribonucleic Acid
The five polybasic amines, methylated bovine serum albumin (MBSA), protamine sulfate, neomycin sulfate, streptomycin sulfate, and diethylaminoethyl-dextran (DEAE-dextran), were exa...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

